Expanding CRISPR Genome Editing Strategies in Hematopoietic Stem and Progenitor Cells for the Treatment of Hematologic Diseases

被引：0
|
作者：
deDreuzy, Edouard
Chalishazar, Aditi
Heath, Jack
Margulies, Carrie M.
Labella, John
Viswanathan, Ramya
Loveluck, Katherine
Chang, KaiHsin
Jayaram, Hariharan
Zuris, John A.
Myer, Vic E.
Albright, Charlie
Cotta-Ramusino, Cecilia
Gori, Jennifer L.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4619
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
    Venkatesan, Vigneshwaran
    Christopher, Abisha Crystal
    Karuppusamy, Karthik, V
    Babu, Prathibha
    Alagiri, Manoj Kumar K.
    Thangavel, Saravanabhavan
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2022, (186):
  • [22] Automated GMP-compatible CRISPR-Cas9 editing of hematopoietic stem and progenitor cells (HSPCs) for the treatment of β-hemoglobinopathies
    Block, M.
    Urena-Bailen, G.
    Grandi, T.
    Aivazidou, F.
    Quednau, J.
    Krenz, D.
    Daniel-Moreno, A.
    Lamsfus-Calle, A.
    Epting, T.
    Handgretinger, R.
    Wild, S.
    Mezger, M.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A179 - A180
  • [23] Resistance of Mouse Hematopoietic Stem and Progenitor Cells to the Genome-Editing with Cas9
    Byambaa, Suvd
    Uosaki, Hideki
    Hara, Hiromasa
    Abe, Tomoyuki
    Nagao, Yasumitsu
    Nureki, Osamu
    Ohmori, Tsukasa
    Hanazono, Yutaka
    MOLECULAR THERAPY, 2017, 25 (05) : 93 - 93
  • [24] Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration
    Bloomer, Hanan
    Smith, Richard H.
    Hakami, Waleed
    Larochelle, Andre
    MOLECULAR THERAPY, 2021, 29 (04) : 1611 - 1624
  • [25] Efficient GMP-compatible CRISPR/Cas mediated genome editing in haematopoietic stem and progenitor cells
    Turchiano, G.
    Haas, S. A.
    Hildenbeutel, M.
    Pennucci, V.
    Cornu, T. I.
    Cathomen, T.
    HUMAN GENE THERAPY, 2017, 28 (12) : A55 - A55
  • [26] GENOME EDITING OF HEMATOPOIETIC STEM CELLS TO ENGINEER BLOOD
    Porteus, Matthew
    EXPERIMENTAL HEMATOLOGY, 2022, 111 : S29 - S29
  • [27] Therapy Development by Genome Editing of Hematopoietic Stem Cells
    Koniali, Lola
    Lederer, Carsten W.
    Kleanthous, Marina
    CELLS, 2021, 10 (06)
  • [28] Immunogenetics Targeted "Genome Editing" of hematopoietic Stem Cells
    Lorenz, Judith
    TRANSFUSIONSMEDIZIN, 2014, 4 (04) : 172 - 173
  • [29] Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
    DeWitt, Mark A.
    Magis, Wendy
    Bray, Nicolas L.
    Wang, Tianjiao
    Berman, Jennifer R.
    Urbinati, Fabrizia
    Heo, Seok-Jin
    Mitros, Therese
    Munoz, Denise P.
    Boffelli, Dario
    Kohn, Donald B.
    Walters, Mark C.
    Carroll, Dana
    Martin, David I. K.
    Corn, Jacob E.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (360)
  • [30] Correction of the Energetic Defects in Pyruvate Kinase Deficiency through Genome Editing in Hematopoietic Stem and Progenitor Cells
    Fananas-Baquero, Sara
    Bustamante, Oscar Quintana
    Dever, Daniel P.
    Alberquilla, Omaira
    Sanchez-Dominguez, Rebeca
    Camarena, Joab
    Turk, Rolf
    Lorenzo, Jose Luis Lopez
    Bianchi, Paola
    Behlke, Mark
    Bueren, Juan A.
    Porteus, Matt
    Segovia, Jose C.
    BLOOD, 2020, 136
12345